The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 7, 2025 | Klichinsky Michael | Chief Scientific Officer | Sell(S) | 57K | $0.25 | $14K |
| Oct 7, 2025 | Klichinsky Michael | Chief Scientific Officer | Option exercise(M) | 57K | $0.11 | $6K |
| Oct 7, 2025 | Klichinsky Michael | Chief Scientific Officer | Option exercise(M) | 57K | — | $0 |
| Oct 3, 2025 | Klichinsky Michael | Chief Scientific Officer | Sell(S) | 119K | $0.26 | $31K |
| Oct 2, 2025 | Klichinsky Michael | Chief Scientific Officer | Sell(S) | 200K | $0.25 | $50K |
| Oct 1, 2025 | Klichinsky Michael | Chief Scientific Officer | Sell(S) | 165K | $0.26 | $43K |
| Jan 28, 2025 | Kelly Steven | President and CEO, Director | Grant(A) | 500K | — | $0 |
| Jan 28, 2025 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 221K | — | $0 |
| Oct 31, 2024 | Cheng Sohanya Roshan | Director | Grant(A) | 39K | — | $0 |
| Jul 1, 2024 | Scadden David | Director | Grant(A) | 39K | — | $0 |
| Jul 1, 2024 | Thorell Marella | Director | Grant(A) | 39K | — | $0 |
| Jun 26, 2024 | Torok Michael | Director | Grant(A) | 19K | — | $0 |
| Jun 26, 2024 | Hohneker John | Director | Grant(A) | 19K | — | $0 |
| Jun 26, 2024 | Morrison Briggs | Director | Grant(A) | 19K | — | $0 |
| Jun 26, 2024 | Zweifach Sanford S | Director | Grant(A) | 19K | — | $0 |
| Jun 17, 2024 | Kelly Steven | President and CEO, Director | Grant(A) | 125K | — | $0 |
| Jun 17, 2024 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 85K | — | $0 |
| Jun 17, 2024 | Morris Richard Steven | Chief Financial Officer | Grant(A) | 85K | — | $0 |
| Apr 1, 2024 | Hohneker John | Director | Grant(A) | 39K | — | $0 |
| Jan 31, 2024 | Kelly Steven | President and CEO, Director | Grant(A) | 438K | — | $0 |
| Jan 31, 2024 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 171K | — | $0 |
| Jan 31, 2024 | Morris Richard Steven | Chief Financial Officer | Grant(A) | 171K | — | $0 |
| Jun 6, 2023 | Morrison Briggs | Director | Grant(A) | 39K | — | $0 |
| Jun 6, 2023 | Ugwumba Chidozie | Director | Grant(A) | 39K | — | $0 |
| Jun 6, 2023 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 238K | — | $0 |
| Jun 6, 2023 | Torok Michael | Director | Grant(A) | 39K | — | $0 |
| Jun 6, 2023 | Morris Richard Steven | Chief Financial Officer | Grant(A) | 238K | — | $0 |
| Jun 6, 2023 | Zweifach Sanford S | Director | Grant(A) | 39K | — | $0 |
| Jun 6, 2023 | Kelly Steven | President and CEO, Director | Grant(A) | 600K | — | $0 |
| Mar 7, 2023 | Morrison Briggs | Director | Grant(A) | 12K | — | — |
| Mar 7, 2023 | Morrison Briggs | Director | Grant(A) | 63K | — | — |
| Mar 7, 2023 | Morrison Briggs | Director | Grant(A) | 34K | — | — |
| Mar 7, 2023 | Zweifach Sanford S | Director | Grant(A) | 413 | — | — |
| Mar 7, 2023 | Zweifach Sanford S | Director | Grant(A) | 185K | — | — |
| Mar 7, 2023 | Torok Michael | Director | Grant(A) | 50K | — | — |
| Mar 7, 2023 | Torok Michael | Director | Grant(A) | 51K | — | — |
| Mar 7, 2023 | Torok Michael | Director | Grant(A) | 320K | — | — |
| Mar 7, 2023 | Morris Richard Steven | Chief Financial Officer | Grant(A) | 331K | — | — |
| Mar 7, 2023 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 484K | — | — |
| Mar 7, 2023 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 112K | — | — |
| Mar 7, 2023 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 57K | — | — |
| Mar 7, 2023 | Klichinsky Michael | Chief Scientific Officer | Grant(A) | 76K | — | — |
| Mar 7, 2023 | Hodits Regina | Director | Grant(A) | 2.3M | — | — |
| Mar 7, 2023 | Ugwumba Chidozie | Director | Grant(A) | 2.2M | — | — |
| Mar 7, 2023 | Kelly Steven | President and CEO, Director | Grant(A) | 416K | — | — |
| Mar 7, 2023 | Kelly Steven | President and CEO, Director | Grant(A) | 626K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).